HSA · registration DE0510188Joonghun Pharmaceutical Lorient Cross-linked Hyaluronic Acid with Lidocaine
- Registration number
- DE0510188
- Model name
- Lorient No. 2; Lorient No. 4; Lorient No. 6
- Model identifier
- Lorient No. 2; Lorient No. 4; Lorient No. 6
- Registration date
- December 30, 2024
- Source update date
- April 16, 2026
- Risk class
- Class D
- Product owner
- Joonghun Pharmaceutical Co., Ltd.
- Registrant / registration holder
- ANDAMAN MEDICAL PTE. LTD.
Lorient is an injectable gel for the treatment of facial defects such as lipoatrophy by restoring volume to the desired correction of facial contours, wrinkles, and folds. · Lorient No. 2 is indicated to be used for superficial dermis injection for fine facial wrinkles and folds or for facial defects. · Lorient No. 4 is indicated to be used for mid to deep dermis injection for moderate to severe facial wrinkles and nasolabial folds. · Lorient No. 6 is indicated to be used for subcutaneous to supraperiosteal injection for cheek augmentation to correct age-related volume defects in mid facial area.
- Product owner address
- 28, Oksansandan-ro, Oksan-myeon, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Korea, South
- Registrant address
- 300 TAMPINES AVENUE 5, #09-02, INCOME AT TAMPINES JUNCTION, Singapore 529653
This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.